Posted in Sapiosexual Chemotherapy-associated steatohepatitis – PubMed July 21, 2025 It is important to identify chemotherapies with steatosis or steatohepatitis as risk factors in order to improve control of the metabolic risk factors associated with the patient and to reinforce monitoring during treatment. https://pubmed.ncbi.nlm.nih.gov/32061473/